Skip to main content

Daiana Natali Lopez

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Daiana Natali Lopez

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

IMPACT- AML

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, Sara Isabel Reidel , Daiana Natali Lopez
Funding agency: EUROPEAN COMMISSION
Funding: 253750
Reference: IMPACT-AML_HE--MISS-CANCER2022
Duration: 01/04/2023 - 31/03/2028

Related news

Vall d’Hebron participates as a reference centre in Spain for early-phase clinical trials and coordinates the national ReALLNet network, promoting research into relapsed acute lymphoblastic leukemia.

The PHOENIX project, involving 13 European institutions, will evaluate for the first time in paediatric patients the drug ibrilatazar from AbilityPharma in a phase I/II clinical trial.

The European initiative Hope4Kids will strengthen and harmonise paediatric palliative care across Europe, with the aim of ensuring comprehensive, high-quality care for all children living with life-threatening or life-limiting conditions.

Related professionals

Raul Pereira Lozano

Raul Pereira Lozano

Technological Infrastructure Unit
Digital Transformation Directorate
Read more
José Antonio Arranz  Amo

José Antonio Arranz Amo

Postdoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Maria del Mar Dalmau Romero

Maria del Mar Dalmau Romero

Postdoctoral researcher
General Surgery
Read more
Laia Martí Melero

Laia Martí Melero

Research technician
Musculoskeletal Tissue Engineering
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.